142 related articles for article (PubMed ID: 11490363)
21. A bacterial ecto-triphosphate diphosphohydrolase similar to human CD39 is essential for intracellular multiplication of Legionella pneumophila.
Sansom FM; Newton HJ; Crikis S; Cianciotto NP; Cowan PJ; d'Apice AJ; Hartland EL
Cell Microbiol; 2007 Aug; 9(8):1922-35. PubMed ID: 17388784
[TBL] [Abstract][Full Text] [Related]
22. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.
Eslami MH; Gangadharan SP; Sui X; Rhynhart KK; Snyder RO; Conte MS
J Vasc Surg; 2000 Jun; 31(6):1149-59. PubMed ID: 10842152
[TBL] [Abstract][Full Text] [Related]
23. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1).
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Thromb Haemost; 2003 Dec; 1(12):2497-509. PubMed ID: 14675084
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous delivery of the gax gene inhibits vessel stenosis in a rabbit model of balloon angioplasty.
Maillard L; Van Belle E; Smith RC; Le Roux A; Denéfle P; Steg G; Barry JJ; Branellec D; Isner JM; Walsh K
Cardiovasc Res; 1997 Sep; 35(3):536-46. PubMed ID: 9415299
[TBL] [Abstract][Full Text] [Related]
25. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets.
Atkinson B; Dwyer K; Enjyoji K; Robson SC
Blood Cells Mol Dis; 2006; 36(2):217-22. PubMed ID: 16476557
[TBL] [Abstract][Full Text] [Related]
26. Development of a novel strategy to target CD39 antithrombotic activity to the endothelial-platelet microenvironment in kidney ischemia-reperfusion injury.
Sashindranath M; Dwyer KM; Dezfouli S; Selan C; Crikis S; Lu B; Yuan Y; Hickey MJ; Peter K; Robson SC; Cowan PJ; Nandurkar HH
Purinergic Signal; 2017 Jun; 13(2):259-265. PubMed ID: 28343356
[TBL] [Abstract][Full Text] [Related]
27. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.
Mizumoto N; Kumamoto T; Robson SC; Sévigny J; Matsue H; Enjyoji K; Takashima A
Nat Med; 2002 Apr; 8(4):358-65. PubMed ID: 11927941
[TBL] [Abstract][Full Text] [Related]
28. The nucleoside triphosphate diphosphohydrolase-1/CD39 is incorporated into human immunodeficiency type 1 particles, where it remains biologically active.
Barat C; Martin G; Beaudoin AR; Sévigny J; Tremblay MJ
J Mol Biol; 2007 Aug; 371(1):269-82. PubMed ID: 17560607
[TBL] [Abstract][Full Text] [Related]
29. Selective neointimal gene transfer in an avian model of vascular injury.
Wang R; Xu M; Marcel R; Bouliane G; Fisher DZ
Atherosclerosis; 1999 Sep; 146(1):71-82. PubMed ID: 10487489
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
[TBL] [Abstract][Full Text] [Related]
31. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation.
Dwyer KM; Robson SC; Nandurkar HH; Campbell DJ; Gock H; Murray-Segal LJ; Fisicaro N; Mysore TB; Kaczmarek E; Cowan PJ; d'Apice AJ
J Clin Invest; 2004 May; 113(10):1440-6. PubMed ID: 15146241
[TBL] [Abstract][Full Text] [Related]
32. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
[TBL] [Abstract][Full Text] [Related]
33. CD39L2, a gene encoding a human nucleoside diphosphatase, predominantly expressed in the heart.
Yeung G; Mulero JJ; McGowan DW; Bajwa SS; Ford JE
Biochemistry; 2000 Oct; 39(42):12916-23. PubMed ID: 11041856
[TBL] [Abstract][Full Text] [Related]
34. Polyethylene glycol diisocyanate decreases platelet deposition after balloon injury of rabbit femoral arteries.
Burchenal JE; Deible CR; Deglau TE; Russell AJ; Beckman EJ; Wagner WR
J Thromb Thrombolysis; 2002 Feb; 13(1):27-33. PubMed ID: 11994557
[TBL] [Abstract][Full Text] [Related]
35. A study of the imbalance in B cell-expressed nucleoside triphosphate diphosphohydrolase 1-induced ADP degradation in graft injury during acute antibody-mediated rejection.
Zhang Y; Wang Y; Zong H; Yang C
Transpl Immunol; 2012 Dec; 27(4):175-8. PubMed ID: 22885372
[TBL] [Abstract][Full Text] [Related]
36. Transmembrane domains confer different substrate specificities and adenosine diphosphate hydrolysis mechanisms on CD39, CD39L1, and chimeras.
Grinthal A; Guidotti G
Biochemistry; 2002 Feb; 41(6):1947-56. PubMed ID: 11827541
[TBL] [Abstract][Full Text] [Related]
37. Adenoviral-mediated expression of antisense RNA to basic fibroblast growth factor reduces tangential stress in arterialized vein grafts.
Hanna AK; Durán WN; Leconte I; Fox JC; Neschis DG; Hobson RW; Golden MA
J Vasc Surg; 2000 Apr; 31(4):770-80. PubMed ID: 10753285
[TBL] [Abstract][Full Text] [Related]
38. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of neointima formation with tissue-type plasminogen activator.
Hilfiker PR; Waugh JM; Li-Hawkins JJ; Kuo MD; Yuksel E; Geske RS; Cifra PN; Chawla M; Weinfeld AB; Thomas JW; Shenaq SM; Dake MD
J Vasc Surg; 2001 Apr; 33(4):821-8. PubMed ID: 11296338
[TBL] [Abstract][Full Text] [Related]
40. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
